… a ; Cotter, Aoife G. b,c … Cotter AG, Sabin CA, Simelane S, et al Relative contribution of
HIV infection, demographics and body mass index to bone mineral density. AIDS 2014; 28:2051–2060. …

Coronavirus disease 2019 (COVID-19), an illness caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, has spread rapidly worldwide, resulting in …

Background. Current or recent use of abacavir for treating human immunodeficiency virus
type 1 (HIV-1) infection has been associated with increased rates of myocardial infarction (MI). …

Methods: Understanding the Pathology of Bone Disease in HIV-infected individuals (HIV
UPBEAT) is a prospective cohort study, enrolled HIV-positive and HIV-negative participants …

Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), has affected over 30 million globally to date. Although …

Background: Recent studies have identified the combination of vancomycin with piperacillin-tazobactam
(VPT) to be associated with increased nephrotoxicity. Multiple, large cohort …

Background The European AIDS Clinical Society (EACS) Guidelines were revised in 2021
for the 17th time with updates on all aspects of HIV care. Key points of the Guidelines update …

Background: Whilst reporting improved renal and bone safety profiles, studies have noted
changes in lipid profiles among people living with HIV (PLWH) receiving antiretroviral therapy (…

Objectives Studies suggest 2 per 1000 people in Dublin are living with HIV, the level above
which universal screening is advised. We aimed to assess the feasibility and acceptability of …

SARS-CoV-2 neutralising antibodies provide protection against COVID-19. Evidence from
early vaccine trials suggested binding antibody thresholds could serve as surrogate markers …